Literature DB >> 202983

The functional pool of brain catecholamines: its size and turnover rate.

R Papeschi.   

Abstract

Behavioral data are reviewed that give evidence for an indiscriminate involvement of brain catecholamines (CA), especially dopamine (DA), in nerve function, regardless of the time elapsed from their synthesis. Critical analysis of biochemical and pharmacological studies shows that a clear-cut distribution of brain catecholamines in two compartments ['newly synthesized' (NS) and 'main storage'] is not at all established, and moreover that there is no adequate proof that the difference in turnover rates attributed to these two supposed pools is due to a preferential extraneuronal release of NS-CA during nerve function rather than to a preferential (nonfunctional) intraneuronal deamination of NS-CA, or at least of NS-DA.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 202983     DOI: 10.1007/bf00432809

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  42 in total

1.  Self-stimulation and noradrenaline: evidence that inhibition of synthesis abolishes responding only if the "reserve" pool is dispersed first.

Authors:  K B Franklin; L J Herberg
Journal:  Brain Res       Date:  1975-10-24       Impact factor: 3.252

2.  Alterations in turnover and endogenous levels of norepinephrine in cerebral cortex following electrical stimulation and acute axotomy of cerebral noradrenergic pathways.

Authors:  J Korf; R H Roth; G K Aghajanian
Journal:  Eur J Pharmacol       Date:  1973-09       Impact factor: 4.432

3.  Tyrosine hydroxylase inhibitors.

Authors:  K E Moore; J A Dominic
Journal:  Fed Proc       Date:  1971 May-Jun

4.  Disposition of newly synthesized amines in cell bodies and terminals of central catechol aminergic neurons. I. Effect of amphetamine and thiorproperazine on the metabolism of CA in the caudate nucleus, the substantia nigra and the ventromedial nucleus of the hypothalamus.

Authors:  F Javoy; M Hamon; J Glowinski
Journal:  Eur J Pharmacol       Date:  1970-05       Impact factor: 4.432

5.  Correlation of the recovery of the granular uptake-storage mechanism and the nerve impulse induced release of ( 3 H)noradrenaline after reserpine.

Authors:  O Almgren; P Lundborg
Journal:  J Pharm Pharmacol       Date:  1971-09       Impact factor: 3.765

6.  Dopamine-norepinephrine: another regulatory step of norepinephrine synthesis in central noradrenergic neurons.

Authors:  A M Thierry; G Blanc; J Glowinski
Journal:  Eur J Pharmacol       Date:  1971-05       Impact factor: 4.432

Review 7.  Modification of norepinephrine synthesis in intact tissue dy drugs and during short-term adrenergic nerve stimulation.

Authors:  N Weiner; G Cloutier; R Bjur; R I Pfeffer
Journal:  Pharmacol Rev       Date:  1972-06       Impact factor: 25.468

8.  Changes in brain concentration of biogenic amines and the antinociceptive effect of morphine in rats.

Authors:  K Reinhold; J Bläsig; A Herz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

9.  Studies on the functional role of intraneuronal monamine oxidase.

Authors:  D E Clarke; S S Sampath
Journal:  J Pharmacol Exp Ther       Date:  1973-12       Impact factor: 4.030

10.  Further evidence for the heterogeneous storage of noradrenaline in central noradrenergic terminals.

Authors:  A M Thierry; G Blanc; J Glowinski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

View more
  1 in total

1.  Effects of low oxygen on the release of dopamine from the rabbit carotid body in vitro.

Authors:  S Fidone; C Gonzalez; K Yoshizaki
Journal:  J Physiol       Date:  1982-12       Impact factor: 5.182

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.